Amgen
AMGN
3,160 hedge funds and large institutions have $162B invested in Amgen in 2026 Q2 according to their latest regulatory filings, with 177 funds opening new positions, 1,271 increasing their positions, 1,233 reducing their positions, and 124 closing their positions.
43% more first-time investments, than exits
New positions opened: 177 | Existing positions closed: 124
1.24% more ownership
Funds ownership: 81.57% → 82.81% (+1.2%)
5% more capital invested
Capital invested by funds: $155B → $162B (+$7.15B)
3% more repeat investments, than reductions
Existing positions increased: 1,271 | Existing positions reduced: 1,233
0% more funds holding
Funds holding: 3,151 → 3,160 (+9)
14% less call options, than puts
Call options by funds: $1.95B | Put options by funds: $2.26B
17% less funds holding in top 10
Funds holding in top 10: 66 → 55 (-11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$861M |
| 2 |
BlackRock
New York
|
+$774M |
| 3 |
Charles Schwab
San Francisco,
California
|
+$774M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$715M |
| 5 |
D.E. Shaw & Co
New York
|
+$381M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$1.87B |
| 2 |
JP Morgan Chase
New York
|
-$1.26B |
| 3 |
Morgan Stanley
New York
|
-$747M |
| 4 |
Primecap Management
Pasadena,
California
|
-$725M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$234M |
AMGN Hedge Fund Activity: Q2 2026 in Review
3,160 of the 8,339 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q2 2026, worth a combined $162B — up 4.6% from $155B a quarter earlier.
Buyers outnumbered sellers: 177 funds opened new AMGN positions and 124 closed out — a net gain of 53 holders — while 1,271 added to existing stakes and 1,233 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $861M. The largest seller was Capital International Investors, cutting an estimated $1.87B.
- 3,160 institutional investors held Amgen (AMGN) as of Q2 2026, up from 3,151 in Q1 2026.
- Funds reported $162B of Amgen stock for Q2 2026, up 4.6% quarter-over-quarter.
- 177 funds opened new Amgen positions in Q2 2026 and 124 closed out, a net change of +53 holders.
- The largest Amgen buyer in Q2 2026 was Wellington Management Group, an estimated $861M added.
- The largest Amgen seller in Q2 2026 was Capital International Investors, an estimated $1.87B sold.
Based on aggregated 13F filings for Q2 2026.